Boots Healthcare Gains Access To U.S. Market Through Clearasil Buy
This article was originally published in The Rose Sheet
Executive Summary
Boots Healthcare International views its acquisition of the Clearasil acne prevention and treatment brand as a possible springboard for creating an OTC drug marketing presence in the U.S.